Abstract
There are two types of bacterial communication systems, those in which the signal produced by bacteria isdirected only at other organisms, and those where the signal is detected by others and self. The latter is involved inadaptation to the environment. The adaptation signals are autoinducers, the response is population density-dependent andhas been termed "quorum sensing". Our current knowledge of bacterial signaling systems indicates that Gram positivebacteria use small peptides for both types of signaling, whereas Gram negative organisms use homoserine lactones asautoinducers. Gram- negative bacteria internalize the signals which act upon an intracellular receptor. Gram-positivebacteria use the signals as ligands for an extracellular receptor of a two-component signaling system. Inhibitors of quorumsensing compounds for both Gram positive and Gram negative bacteria are being explored. Signal inhibitors could bepotentially effective in impeding biofilm formation, which might prolong the utility of the currently available antibioticsin this era of antibiotic resistance. In this review, we will explore both bacteria-host and bacteria-bacteria communicationsystems, with an emphasis on inhibitors of these systems both natural and synthetic.
Mini-Reviews in Medicinal Chemistry
Title: Chemical Communication-Do We Have a Quorum?
Volume: 6 Issue: 7
Author(s): Monika I. Konaklieva and Balbina J. Plotkin
Affiliation:
Abstract: There are two types of bacterial communication systems, those in which the signal produced by bacteria isdirected only at other organisms, and those where the signal is detected by others and self. The latter is involved inadaptation to the environment. The adaptation signals are autoinducers, the response is population density-dependent andhas been termed "quorum sensing". Our current knowledge of bacterial signaling systems indicates that Gram positivebacteria use small peptides for both types of signaling, whereas Gram negative organisms use homoserine lactones asautoinducers. Gram- negative bacteria internalize the signals which act upon an intracellular receptor. Gram-positivebacteria use the signals as ligands for an extracellular receptor of a two-component signaling system. Inhibitors of quorumsensing compounds for both Gram positive and Gram negative bacteria are being explored. Signal inhibitors could bepotentially effective in impeding biofilm formation, which might prolong the utility of the currently available antibioticsin this era of antibiotic resistance. In this review, we will explore both bacteria-host and bacteria-bacteria communicationsystems, with an emphasis on inhibitors of these systems both natural and synthetic.
Export Options
About this article
Cite this article as:
Konaklieva I. Monika and Plotkin J. Balbina, Chemical Communication-Do We Have a Quorum?, Mini-Reviews in Medicinal Chemistry 2006; 6 (7) . https://dx.doi.org/10.2174/138955706777698589
DOI https://dx.doi.org/10.2174/138955706777698589 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
Current Topics in Medicinal Chemistry Application of Immunological Techniques (from Vaccination to Final Measurements) in Determination of Pharmaceutical Residues in Environmental Samples
Current Analytical Chemistry Single Chemical Entity Legal Highs: Assessing the Risk for Long Term Harm
Current Drug Abuse Reviews Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Non-Antidepressant Treatment of Social Anxiety Disorder: A Review
Current Clinical Pharmacology Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia
Current Alzheimer Research Artificial Intelligence Techniques for Colorectal Cancer Drug Metabolism: Ontologies and Complex Networks
Current Drug Metabolism Two Nitrogen-containing Ligands as Inhibitors of Metal-Induced Amyloid β-Peptide Aggregation
CNS & Neurological Disorders - Drug Targets Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson`s Disease
CNS & Neurological Disorders - Drug Targets RNAi Silencing in Mouse Models of Neurodegenerative Diseases
Current Drug Delivery NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review
Current Neuropharmacology BACE1 Structure and Function in Health and Alzheimers Disease
Current Alzheimer Research Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
Current Alzheimer Research Enhancing Yeast Transcription Analysis Through Integration of Heterogeneous Data
Current Genomics Excellent Exo/Endo-Selectivity in the 1,3-Dipolar Cycloaddition of Cyclic Azomethine Ylide: Exploring the Facile Investigation of Cocaine Antagonists
Letters in Organic Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Correlations Between Cerebellar and Brain Volumes, Cognitive Impairments, ApoE Levels, and APOE Genotypes in Patients with AD and MCI
Current Alzheimer Research Astrocyte Signaling and Multiple Sclerosis
Current Signal Transduction Therapy The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
Current Neuropharmacology